Cargando…
The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy
BACKGROUND: Patients chronically infected with hepatitis C virus (HCV) require significantly different durations of therapy and achieve substantially different sustained virologic response rates to interferon-based therapies, depending on the HCV genotype with which they are infected. There currentl...
Autores principales: | Pang, Phillip S., Planet, Paul J., Glenn, Jeffrey S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719056/ https://www.ncbi.nlm.nih.gov/pubmed/19668364 http://dx.doi.org/10.1371/journal.pone.0006579 |
Ejemplares similares
-
Evolution of Interferon-Based Therapy for Chronic Hepatitis C
por: Chen, Chun-Hao, et al.
Publicado: (2010) -
Response Guided Interferon Therapy for Genotype 3 of Chronic Hepatitis C: Compliance and Outcome
por: Sarwar, Shahid, et al.
Publicado: (2015) -
Serum Interferon-Related MicroRNAs as Biomarkers to Predict the Response to Interferon Therapy in Chronic Hepatitis C Genotype 4
por: Motawi, Tarek Kamal, et al.
Publicado: (2015) -
Impact of Interferon Lambda 4 Genotype on Interferon‐Stimulated Gene Expression During Direct‐Acting Antiviral Therapy for Hepatitis C
por: Ramamurthy, Narayan, et al.
Publicado: (2018) -
Peripheral blood toll-like receptor 4 correlates with rapid virological response to pegylated-interferon and ribavirin therapy in hepatitis C genotype 1 patients
por: Lee, Chuan-Mo, et al.
Publicado: (2016)